Publisher
Springer International Publishing
Reference44 articles.
1. Abraham, H. D., Aldridge, A. M., & Gogia, P. (1996). The psychopharmacology of hallucinogens. Neuropsychopharm, 14, 285–298.
2. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington: American Psychiatric Publishing.
3. Buchanan, J. F., & Brown, C. R. (1988). Designer drugs. A problem in clinical toxicology. Medical Toxicology and Adverse Drug Experience, 3, 1–17.
4. Carhart-Harris, R. L., King, L. A., & Nutt, D. J. (2011). A web-based survey on mephedrone. Drug and Alcohol Dependence, 118, 19–22.
5. Fantegrossi, W. E., Murnane, K. S., & Reissig, C. J. (2008). The behavioral pharmacology of hallucinogens. Biochemical Pharmacology, 75, 17–33.